Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
39 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- O'Neal Comprehensive Cancer Center
Birmingham, Alabama, United States
- Banner Md Anderson
Gilbert, Arizona, United States
- Honorhealth (vgpcc Cancer Transplant Institute)
Scottsdale, Arizona, United States
- the University of Arizona Cancer Center
Tucson, Arizona, United States
- University of California
Irvine, California, United States
- Ucla
Los Angeles, California, United States
- Uf-Health Cancer Center Gainesville
Gainesville, Florida, United States
- Baptist Md Anderson
Jacksonville, Florida, United States
- Uf-Health Jacksonville
Jacksonville, Florida, United States
- Adventhealth Medical Group Blood and Marrow Transplant at Orlando
Orlando, Florida, United States
- Georgia Cancer Center at Augusta University
Augusta, Georgia, United States
- Rush University
Chicago, Illinois, United States
- Decatur Memorial Hospital-Cancer Care Specialists of Central Il
Decatur, Illinois, United States
- Loyola University Medical Center
Hines, Illinois, United States
- Franciscan Health Indianapolis
Indianapolis, Indiana, United States
- the University of Kansas Cancer Center
Westwood, Kansas, United States
- University of Ky- Markey Cancer Center
Lexington, Kentucky, United States
- Norton Cancer Institute
Louisville, Kentucky, United States
- Ochsner Benson Cancer Center
Jefferson, Louisiana, United States
- Tulane University
New Orleans, Louisiana, United States
- Henry Ford Cancer Institute
Detroit, Michigan, United States
- the University of Mississippi Medical Center
Jackson, Mississippi, United States
- New York Medical College
Valhalla, New York, United States
- Novant Health Cancer Institute - Elizabeth (hematology)
Charlotte, North Carolina, United States
- East Carolina University
Greenville, North Carolina, United States
- Vidant Oncology
Kinston, North Carolina, United States
- Novant Health Cancer Institute - Forsyth (hematology)
Winston-Salem, North Carolina, United States
- Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- University of Cincinnati Cancer Center
Cincinnati, Ohio, United States
- Seidman Cancer Center, University Hospitals, Cleveland Medical Center
Cleveland, Ohio, United States
- Prisma Health Cancer Institute
Greenville, South Carolina, United States
- Avera Medical Group
Sioux Falls, South Dakota, United States
- Ut Southwestern
Dallas, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- University of Vermont Medical Center
Burlington, Vermont, United States
- University of Virginia Health System
Charlottesville, Virginia, United States
- Multicare Institute for Research and Innovation
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Nov 2019
- Primary completion
- 7 Jan 2026
- Completion
- 7 Jan 2026
- Last update posted
- 22 Jan 2026
- Registered enrollment
- 167
- Registry id
- NCT03926624
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.